Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response – 6-month interim analysis of the FURGGHORN study
Asia-Pacific Journal of Ophthalmology · 2026-03 · 15 (2) · 100299
DOI: 10.1016/j.apjo.2026.100299 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2026-03. Verfasst von Long T Phan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cureos Research, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Wet Macular Degeneration. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cureos Research, Sydney, NSW, Australia.
- Sydney Retina Clinic, Sydney, NSW, Australia; Strathfield Retina Clinic, Strathfield, NSW, Australia.
- Eastwood Eye Specialists, Eastwood, NSW, Australia.
- Sydney Retina Clinic, Sydney, NSW, Australia; Save Sight Institute, The University of Sydney, Sydney, NSW, Australia; Lane Cove Eye Surgery, Lane Cove, NSW, Australia; Department of Ophthalmology, Sydney Eye Hospital, S…
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore.
- EyeClinic Albury Wodonga, Albury, NSW, Australia.
Förderung
- Roche
Zitieren
APA
Phan, L. T., Chin, J., Broadhead, G. K., Hong, T. H., Mehta, H., Chang, J. H., Fraser-Bell, S., Cheung, C. M. G., Sun, C. Z., Luckie, A. P., Wickremasinghe, S. S., Liew, G., Gilhotra, J. S., Simunovic, M. P., Verma, N., & Chang, A. A. (2026). Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response – 6-month interim analysis of the FURGGHORN study. Asia-Pacific Journal of Ophthalmology, 15(2), 100299. https://doi.org/10.1016/j.apjo.2026.100299
Vancouver
Phan LT, Chin J, Broadhead GK, Hong TH, Mehta H, Chang JH, et al. Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response – 6-month interim analysis of the FURGGHORN study. Asia-Pacific Journal of Ophthalmology. 2026;15(2):100299. doi:10.1016/j.apjo.2026.100299
BibTeX
@article{Phan2026,
author = {Phan, Long T and Chin, Jennifer and Broadhead, Geoffrey K and Hong, Thomas H and Mehta, Hemal and Chang, John H and Fraser-Bell, Samantha and Cheung, Chui Ming Gemmy and Sun, Christopher Ziyu and Luckie, Alan P and Wickremasinghe, Sanjeewa S and Liew, Gerald and Gilhotra, Jagjit S and Simunovic, Matthew P and Verma, Nitin and Chang, Andrew A},
title = {Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response – 6-month interim analysis of the FURGGHORN study},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2026},
volume = {15},
number = {2},
pages = {100299},
doi = {10.1016/j.apjo.2026.100299}
}
EUVIMED